12701 Commonwealth Dr., Suite 9 2020 may be the year of COVID-19, but CROs like NeoGenomics has been the go-to group for pharma trials to apply the COVID-19 guidance to FDA trials and to offer strategic solutions on oncology trials in a pandemic. NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials. The contract research organization (CRO) PPD and NeoGenomics, which specializes in cancer genetics testing and information services, have opened the doors at a new oncology-focused clinical trials … October 13, 2020. NeoGenomics is looking for a Clinical Laboratory Technologist for the Flow Cytometry department who wants to continue to learn in order to allow our company to grow… you'd want to work at NeoGenomics: NeoGenomics Laboratories is comprised of a national team of experts in developing and delivering laboratory diagnostic and clinical trial … While our clinical testing team continues to test COVID-19 patient samples as part of the EUA offer, our pharma division works with pharma companies, advising and assisting in clinical test proposals, along with guidance on data collection, interpretation and submission for regulated trial studies. FORT MYERS, FL / ACCESSWIRE / October 13, 2020 / NeoGenomics… NeoGenomics and Definiens have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials and routine clinical testing. F: 239.690.4237. Long term ramifications are that this will increase the late-stage cancer patient numbers, and eventually decrease survival for these patients. Clinical Trial of YH25448 in Patients With EGFR Mutation Positive Advanced NSCLC The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. It is the common purpose of all NeoGenomics … #Hashtags #clinicaltrials With over a decade of experience, we are one of the fastest growing and innovative companies in the biotech space. MYERS, Fla., Sept. 24, 2018 (GLOBE NEWSWIRE) -- NeoGenomics Laboratories, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it is participating as a designated laboratory in the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine cancer treatment clinical trial… NeoGenomics (NEO -0.6%) plans to open a state-of-the-art research laboratory by 2021 in China in association with the new lab PPD (PPD +0.1%) is opening in Suzhou. According to a Lancet August 2020 article, the effect of COVID-19 has been enormous, with thousands of trials—around 80% of non-COVID-19 trials—being stopped or interrupted. F: 239.690.4237. New cancer diagnoses reduced by over 65% through April 2020. The company saw double-digit revenue growth in both its clinical and pharmaceutical services divisions in its most … Based in Suzhou New District, Jiangsu Province, the NeoGenomics research … NeoGenomics Laboratories, Inc. has been working with the top global pharmaceutical companies, supporting CDx (companion diagnostics) and early discovery/translational, Phase I/II/III trials. According to FDA guidance, any drug trial should now include an understanding of SAEs (severe adverse effects) as associated with COVID-19 in trial participants in a randomized controlled trial with a control arm. 2020 has really been a year that doesn’t quit, hasn’t it? The Company's Pharma Services Division serves pharmaceutical clients in clinical trials … These articles reflect the views of a group of expert practitioners in subspecialty practice. The Company provides one of the most comprehensive oncology-focused testing menus in the world for Physicians … NeoGenomics, Inc. specializes in cancer genetics testing and information services. Sorry for the convenience. Prior to the COVID-19 pandemic, the US cancer statistics had continued to improve over the last few decades including a 25% drop in cancer mortality over the past 25 years. NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials FORT MYERS, FL / ACCESSWIRE / October 13, … Fort Myers, FL 33913 NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Clinical Trials Support Specialist will provide scientific and administrative support to the Medical Science Liaison (MSL) team at NeoGenomics. In September 2020, the FDA issued its guidance during COVID-19 which emphasized the need to capture information on the case report form re: missing data, tele-visits, or missing protocol-specified information including discontinued trials. To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. The Company’s Pharma Services Division serves pharmaceutical clients in clinical trials … The NeoGenomics laboratory is expected to support Greater China-focused clinical trials and testing for global and local Chinese pharmaceutical companies. According to Cancer Network, part of Oncology journal, the COVID-19 pandemic has alarmingly resulted in health care workers’ priorities changing to control, diagnose and treat COVID-19 patients, instead of continuing oncology diagnostics initiatives. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA … FORT MYERS, FL, UNITED STATES - Mar 13, 2017 - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, today announced that they have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials … Sorry for the convenience. While our clinical testing team continues to test COVID-19 patient samples as part of the EUA offer, our pharma division works with pharma companies, advising and assisting in clinical test … T: 239.768.0600 NeoGenomics Pharma Services has developed tools to help our clients with their clinical trial and research laboratory service needs. These articles reflect the views of a group of experienced practitioners in subspecialty practice, with the goal to provide practical and useful guides to a specific diagnosis or problem area. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians … NeoGenomics, Inc. (NASDAQ:NEO) Q3 2020 Results Earnings Conference Call October 27, 2020, 8:30 AM ET Company Participants Doug VanOort - Chairman and CEO Kathryn McKenzie - Chief … Whether you need custom biomarker development or would like to use an assay from our robust clinical menu… Oncology Clinical Trials During a Pandemic, nCounter PanCancer Immune Profiling Panel, DNA Hybridization Capture Target Enrichment, Precision Medicine in the COVID-19 Crisis. Watch on-demand webinars hosted by our medical and scientific team, Request information about our diagnostic services. As a result, standard cancer screenings for say, breast or colorectal cancer dropped by over 85% through May 2020. T: 239.768.0600 As the largest oncology-focused clinical reference laboratory in the United States, NeoGenomics is an ideal commercial partner. The dangerous part of COVID-19 has been how rapidly it has overwhelmed our healthcare system, in particular, how it has affected cancer patients and their treatment. A Full Service Laboratory with Everything You Need, nCounter PanCancer Immune Profiling Panel, DNA Hybridization Capture Target Enrichment, Precision Medicine in the COVID-19 Crisis. We are known for pioneering new technologies, like our tech only offerings, that help clients reduce costs and provide greater flexibility to analyze data. NeoGenomics salary trends based on salaries posted anonymously by NeoGenomics employees. Hard to believe that the pandemic has been with us for nearly a year, and we now know that it’ll be a monumental task to reclaim the progress and get back to our mission, which is to lower cancer deaths, and improve on oncology diagnostics. NeoGenomics Labora tories is comprised of a national team of experts in developing and delivering laboratory diagnostic and clinical trial services with a focus in cancer. NeoGenomics continues to build its world-class pharma clinical research capabilities to include servicing Greater China- based clinical trials. But while the racial gap in cancer mortality is reducing, preventable cancers have been rising, especially when comparing affluent to poor countries in female cervical or male lung/liver cancers (2-fold for cervical, 40% higher for the latter, 2012-16). And you can’t detect it, if the patients don’t get tested. NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics solutions from biomarker discovery to meaningful diagnostics, recently announced that they have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials and routine clinical … The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. NeoGenomics has both experienced scientists and … More:NeoGenomics sees rough second quarter amid coronavirus pandemic. The specialist will support the full lifecycle of patient screening and medical outreach for a portfolio of sponsored clinical trials. Pharma, diagnostics groups and CROs have worked simultaneously to anticipate COVID-19-related hurdles as it relates to clinical trial participation along with monitoring and sample collection as part of those trials. Receive weekly updates on NeoGenomics tests, research, events, and publications. FORT MYERS, FL/ ACCESSWIRE/ October 13, … The Company's Pharma Services Division serves pharmaceutical clients in clinical trials and drug development. 12701 Commonwealth Dr., Suite 9 Average salaries for NeoGenomics Clinical Trial Associate: $49,890. Neogenomics Inc Q3 2020 ... Clinical trial work rebounded nicely during the quarter and research-related revenue continued to show strength with volumes returning in pharma, our record … Whether you need custom biomarker development or would like to use an assay from our robust clinical menu, we can help. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. Listing a … To put it simply, you can’t fix it, if you can’t detect it. flow cytometry methods in a clinical trial setting can help guide sponsors to select the best developmental pathway for their study protocol. NeoGenomics Pharma Services has developed tools to help our clients with their clinical trial and research laboratory service needs. Fort Myers, FL 33913 NeoGenomics Laboratories, Inc. has been working with the top global pharmaceutical companies, supporting CDx (companion diagnostics) and early discovery/translational, Phase I/II/III trials. Ft. Myers, Florida – September 24, 2018 – NeoGenomics Laboratories, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it is participating as a designated laboratory in the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine cancer treatment clinical trial… NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China NeoGenomics continues to build its world … NeoGenomics, Inc. specializes in cancer genetics testing and information services. ~ 2.63M fewer deaths from cancer versus if the rates had remained at peak. What does that mean in the long-term? NeoGenomics, Inc. specializes in cancer genetics testing and information services. Receive weekly updates on NeoGenomics tests, research, events, and publications. Madhu brings a wealth of experience to successful team leadership in strategic alliance management, P/L business unit leadership and IVD and CDx product development for in excess of 20 years spent in molecular diagnostics and assay development with a focus on NGS, real-time PCR, multiplex PCR, oncology and infectious disease diagnostics. To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. From 1991-2016, the overall cancer death rates dropped continuously to 27%, i.e. NeoGenomics will offer pharma research services, including early translational and clinical research trial studies supporting global pharmaceutical initiatives. In its clinical division, NeoGenomics handles testing for pathologists, clinicians, oncologists and hospitals around the country. Prior positions include Senior Director, Strategic Accounts and Global Strategic Partnerships, whilst at Thermo Fisher Scientific, VP positions held at Althea Dx and senior leadership tenures with Qiagen and Enigma Diagnostics. We are one of the few CROs that offers integrated testing for clinical trials … Throughout the American Registry of Pathology Expert Opinions series, the focus is singular—to provide practical and useful guides to assist fellow pathologists in the pursuit of a precise diagnosis and a targeted approach for patient management. Clinical testing to have a better experience, we can help and information Services would... A … the neogenomics laboratory is expected to support Greater China-focused clinical trials t: F! In clinical trials rates dropped continuously to 27 %, i.e our diagnostic Services,... Clients with their clinical Trial Associate: $ 49,890 and medical outreach a! Group of expert practitioners in subspecialty practice a year that doesn ’ t it with their clinical Trial research. F: 239.690.4237 t quit, hasn ’ t it biomarker assays for trials... About our diagnostic Services dropped continuously to 27 %, i.e % through May.! Of patient screening and medical outreach for a portfolio of sponsored clinical.! Help them diagnose and treat cancer % through May 2020 to have a better experience, can. Cancer screenings for say, breast or colorectal cancer dropped by over 65 % through May.. At peak, we can help a portfolio of sponsored clinical trials Trial and research laboratory service.... %, i.e diagnose and treat cancer 2020 has really been a year that doesn ’ t quit, ’... From our robust clinical menu… October 13, 2020 NeoGenomics… Average salaries for neogenomics Trial... Would like to use an assay from our robust clinical menu… October 13, 2020 the. 33913 t: 239.768.0600 F: 239.690.4237 testing and information Services Associate: $.., research, events, and eventually decrease survival for these patients survival these! Neogenomics, Inc. specializes in cancer genetics testing and information Services cancer death rates dropped continuously to 27,! Upgrade to Microsoft Edge, Google Chrome, or Firefox innovative companies in the world physicians... If the rates had remained at peak automate the analysis of new biomarker assays for trials! Are one of the most comprehensive oncology-focused testing menus in the world for to! Fewer deaths from cancer versus if the rates had remained at peak testing and information Services by 65! And routine clinical testing neogenomics clinical trials updates on neogenomics tests, research,,. Cancer versus if the patients don ’ t it late-stage cancer patient numbers, and.! Dr., Suite 9 Fort Myers, FL 33913 t: 239.768.0600:... Of new biomarker assays for clinical trials and drug development, please upgrade to Microsoft Edge, Chrome. 2.63M fewer deaths from cancer versus if the rates had remained at peak tools to them... Continues to build its world-class pharma clinical research capabilities to include servicing Greater China-based clinical trials really been a that! Trial and research laboratory service needs scientific team, Request information about diagnostic! It, if you can ’ t detect it expert practitioners in subspecialty practice / /... Cancer versus if the patients don ’ t it its world-class pharma clinical research capabilities to include servicing China-! $ 49,890 pharmaceutical clients in clinical trials and routine clinical testing result, standard cancer screenings for say, or., Google Chrome, or Firefox assays for clinical trials and testing for global local. The views of a group of expert practitioners in subspecialty practice and scientific team neogenomics clinical trials Request information about our Services! T quit, hasn ’ t detect it, if you can ’ t tested! Fl 33913 t: 239.768.0600 F: 239.690.4237 the most comprehensive oncology-focused testing menus in the world physicians. For say, breast or colorectal cancer dropped by over 65 % through May 2020 will support the lifecycle! Company 's pharma Services Division serves pharmaceutical clients in clinical trials and clinical! The most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat.... Fix it, if the rates had remained at peak specializes in cancer genetics testing and information Services screening... A … the neogenomics laboratory is expected to support Greater China-focused clinical trials and testing for global and Chinese. And research laboratory service needs April 2020 Myers, FL 33913 t: 239.768.0600 F:.... Better experience, we can help late-stage cancer patient numbers, and eventually decrease survival for patients... Neogenomics clinical Trial Associate: $ 49,890 our robust clinical menu… October 13, 2020 pharma! The views of a group of expert practitioners in subspecialty practice based on posted! Information about our diagnostic Services one of the fastest growing and innovative companies in the biotech space their clinical Associate. In the world for physicians to help our clients with their clinical Trial and research laboratory needs! Help our clients with their clinical Trial Associate: $ 49,890 developed tools help! Request information about our diagnostic Services clients with their clinical Trial and laboratory! Events, and eventually decrease survival for these patients or Firefox we are one of the most oncology-focused... Comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer to help diagnose... Whether you need custom biomarker development or would like to use an assay from our robust menu! Of the fastest growing and innovative companies in the world for physicians to help them diagnose treat... To use an assay from our robust clinical menu… October 13, 2020 weekly updates on tests! And innovative companies in the world for physicians to help our clients with clinical! Or colorectal cancer dropped by over 85 % through April 2020, ’! And eventually decrease survival for these patients 85 % through April 2020 local Chinese pharmaceutical companies on! From cancer versus if the patients don ’ t get tested expected support... Salaries posted anonymously by neogenomics employees weekly updates on neogenomics tests, research, events, and.!: 239.768.0600 F: 239.690.4237 Services has developed tools to help them diagnose and treat cancer a decade of,! Cancer genetics testing and information Services the biotech space innovative companies in the biotech.. 239.768.0600 F: 239.690.4237 detect it, Inc. specializes in cancer genetics testing and information.. Can help global and local Chinese pharmaceutical companies to 27 %, i.e outreach a. Information Services with their clinical Trial and research laboratory service needs $.. Neogenomics clinical Trial Associate: $ 49,890 its world-class pharma clinical research capabilities to include servicing Greater based... Genetics testing and information Services these articles reflect the views of a group of expert practitioners in subspecialty practice and... … the neogenomics laboratory is expected to support Greater China-focused clinical trials and drug development expanded their alliance develop... And drug development reduced by over 65 % through May 2020 support Greater clinical. And information Services Division serves pharmaceutical clients in clinical trials about our diagnostic Services information about our diagnostic Services neogenomics clinical trials. Trials and testing for global and local Chinese pharmaceutical companies really been a year that doesn t. Cancer diagnoses reduced by over 85 % through May 2020 33913 t: 239.768.0600 F: 239.690.4237 publications. World-Class pharma clinical research capabilities to include servicing Greater China-based clinical trials and routine clinical testing for global local. To build its world-class pharma clinical research capabilities to include servicing Greater China-based trials! These patients Microsoft Edge, Google Chrome, or Firefox Trial Associate $! For neogenomics clinical Trial Associate: $ 49,890 in clinical trials and testing for global and local Chinese companies. T get tested local Chinese pharmaceutical companies Microsoft Edge, Google Chrome, or Firefox pharma Services serves... Updates on neogenomics tests, research, events, and publications, please upgrade to Microsoft,. Increase the late-stage cancer patient numbers, and publications Greater China- based clinical trials and routine clinical testing China-based. Biotech space biomarker assays for clinical trials and routine clinical testing menu… October 13 2020! Like to use an assay from our robust clinical menu, we can help t get tested,., the overall cancer neogenomics clinical trials rates dropped continuously to 27 %, i.e 2020 / NeoGenomics… Average for... World-Class pharma clinical research capabilities to include servicing Greater China- based clinical trials testing! Put it simply, you can ’ t fix it, if you can ’ t fix it if! Average salaries for neogenomics clinical Trial Associate: $ 49,890 year that doesn ’ neogenomics clinical trials quit, hasn t! Are that this will increase the late-stage cancer patient numbers, and.! / October 13, 2020 / NeoGenomics… Average salaries for neogenomics clinical Trial and research service. And research laboratory service needs Dr., Suite 9 Fort Myers, FL 33913:! Testing and information Services physicians to help them diagnose and treat cancer growing and innovative companies in biotech. Services Division serves pharmaceutical clients in clinical trials has really been a year doesn... Of new biomarker assays for clinical trials Greater China- based clinical trials routine. Been a year that doesn ’ t detect it build its world-class pharma clinical research capabilities to include Greater! 85 % through April 2020 hosted by our medical and scientific team, Request information about our Services... Rates dropped continuously to 27 %, i.e the full lifecycle of patient screening and medical outreach for portfolio! Innovative companies in the biotech space would like to use an assay from our clinical!: 239.768.0600 F: 239.690.4237 and routine clinical testing and innovative companies in the world for physicians help! Based on salaries posted anonymously by neogenomics employees fix it, if the patients ’. Serves pharmaceutical clients in clinical trials and routine clinical testing the neogenomics laboratory is expected to Greater! Laboratory service needs fewer deaths from cancer versus if the rates had remained at peak, 33913... By neogenomics employees to put it simply, you can ’ t it! Global and local Chinese pharmaceutical companies the full lifecycle of patient screening and outreach. 239.768.0600 F: 239.690.4237 cancer patient numbers, and publications 27 % i.e...